Skip to Content

Rituxan Prices, Coupons and Patient Assistance Programs

Rituxan (rituximab) is a member of the antirheumatics drug class and is commonly used for Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and others.

Rituxan Prices

This Rituxan price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Rituxan intravenous solution (10 mg/mL) is around $915 for a supply of 10 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Solution

10 mg/mL Rituxan intravenous solution
from $915.41 for 10 milliliters
Quantity Per unit Price
10 milliliters $91.54 $915.41
50 milliliters $90.86 $4,542.81

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Rituxan Coupons and Rebates

Rituxan offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Rituxan Genetech BioOncology Co-pay Card: Eligible patients may receive an annual savings of up to $25,000 per year; for additional information contact the program at 855-692-6729

Applies to:Rituxan
Number of uses:12 times within calendar year
ExpiresJuly 1, 2019

Patient Assistance Programs for Rituxan

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Genentech Access to Care Foundation (Rituxan Rheumatology)

Elligibility requirements:

  1. Must have no prescription coverage or been denied coverage
  2. Gross annual household income at or below $100,000
  3. FDA-approved diagnosis
  4. Must be treated by US licensed healthcare provider
  5. Rituxan RA: Rheumatoid Arthritis Rituxan MPA: Microscopic Polyangilitis Rituxan GPA: Granulomatosis with Polyangilits (Formerly known as Wegener

Applicable drugs:

  • Rituxan (rituximab) Injection (NHL & CLL)

Provider: Genentech Access to Care Foundation (Rituxan BioOncology)

Elligibility requirements:

  1. Must have no prescription coverage or been denied coverage
  2. Gross annual household income at or below $100,000
  3. Not specified
  4. Must be treated by US licensed healthcare provider
  5. Rituxan NHL: Non-Hodgkins Lymphoma Rituxan CLL: Chronic Lymphocytic Leukemia

Applicable drugs:

  • Rituxan (rituximab) Injection (NHL & CLL)
  • Rituxan Hycela (rituximab-hyaluronidase)

Provider: HealthWell Foundation Copay Program

Elligibility requirements:

  1. May have insurance
  2. Varies
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. This program provides financial assistance to eligible individuals to cover coinsurance, copayments, healthcare premiums and deductibles for certain treatments. Also, for those who are eligible for health insurance, but cannot afford the insurance premium, the foundation may be able to help by paying some or all of the medical portion of insurance premiums. The patient is being treated for a specific disease for which funding is available and has insurance that covers the treatment for this disease. Call for most recent medications as the list is subject to change.

Applicable drugs:

  • Rituxan (rituximab)

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Rituxan (rituximab)
Hide